Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News Technology Industry News Can Bristol Myers Squibb turn Claude into pharma’s first enterprise AI operating layer? Bristol Myers Squibb is moving Claude beyond chatbots. The bigger test is whether agentic AI can change how pharma actually works. byPallavi MadhirajuMay 25, 2026